drugset / Trial / NCT00701259

Efficacy/Safety of Lansoprazole in Patients With Frequent Nighttime Heartburn

NCT00701259

Phase 3 Completed 852 enrolled Novartis
RandomizedParallel-groupTriple-blindTreatment

Summary

Heartburn, a burning sensation in the chest or throat, occurs in many individuals when acidic stomach contents move upward into the esophagus from the stomach. This study will investigate the safety and efficacy of lansoprazole 15 mg or 30 mg administered once a day in preventing frequent nighttime heartburn.

Timeline

Start
2007-01
Primary completion
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Lansoprazole Other / unclassified 15 mg
Subject Lansoprazole Other / unclassified 30 mg

Indications

No indication recorded.